William McConnell

Bill McConnell has led The Deal 's coverage of the nation's capital since becoming Washington bureau chief in 2005. His reporting has covered a range of issues critical to the deal community -- antitrust, financial reform, corporate accounting, tax policy, the impact of national security concerns on dealmaking and the effect consolidation has had on American society. Prior to joining The Deal, Bill was the Washington correspondent for Broadcasting & Cable, where he spent seven years reporting on the debate over media ownership, the FCC's crackdown on broadcast indecency and the rollout of digital television.

Recent Articles By The Author

Why More Limbo on Healthcare Reform Is Bad News for Hospital Stocks

Why More Limbo on Healthcare Reform Is Bad News for Hospital Stocks

More Limbo on Healthcare Reform is Bad News for Hospital Stocks

Despite Raising 2017 Outlook Again, UnitedHealth's Q2 Fails to Juice Investors

Despite Raising 2017 Outlook Again, UnitedHealth's Q2 Fails to Juice Investors

Second-quarter revenue of $50.1 billion was 8% higher year-over-year, leading to improved guidance for the rest of this year.

Nektar Shares Boosted by Promising Results on Opioid Addiction Study

Nektar Shares Boosted by Promising Results on Opioid Addiction Study

NKTR-181 is the first full mu-opioid agonist molecule designed to provide potent pain relief without the high levels of euphoria that can lead to abuse and addiction with standard opioids.

MiMedx Spikes After Q2 Earnings Beat; Mylan Pops on New Breast Cancer Drug -Biotech Movers

MiMedx Spikes After Q2 Earnings Beat; Mylan Pops on New Breast Cancer Drug -Biotech Movers

Here's what moving in the world of Biotech

Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher

Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher

The redemption follows the July 10 announcement that Valeant would pay down $811 million of its senior secured term loans.